Medtronic CE-marks mechanical heart valve:
This article was originally published in Clinica
Executive Summary
Medtronic has CE-marked for sale in Europe its Advantage bileaflet mechanical heart valve as a replacement for diseased or damage valves that no longer efficiently control blood flow between the heart's chambers. The Advantage valve, which employs a patented pyrolytic carbon technology, called Surface Engineering, provides smooth transitional surfaces for gentle, unobstructed blood flow, which is "key" to improved patient outcomes, says the firm. Additionally, the device's low profile design can make it easier to implant, says the firm.
You may also be interested in...
Probiotics And Cold Remedies Boost Recordati In 2023
Italy's Recordati saw its OTC sales grow by 10% in 2023 driven by the recovery of the cough & cold market and a growing demand for probiotics.
Falling Sales Force New Priorities At Roche
The Swiss major brings a new ruthlessness to the compounds in its pipeline: if they’re not first or best, they’re out.
Human Cell-Secreted Proteins Offer A Wellspring Of Potential Therapeutics
CEO Hanadie Yousef leads Juvena Therapeutics in utilizing an AI-based platform that analyzes cell-secreted proteins to identify potential therapeutics. One of their first near-clinical assets could complement GLP-1s.